Latest Articles
Background and Objectives This study examined Inflammatory Bowel Disease (IBD) management and outcomes during pregnancy in a tertiary care setting, focusing on disease activity, medication use, and ...
Background Advanced combination therapy with biologics and small molecules has seen more widespread implementation for inflammatory bowel disease (IBD). However, there is a paucity of data available ...
Background/Aims Filgotinib (FIL), a Janus kinase (JAK) inhibitor, shows clinical efficacy in moderate to severe ulcerative colitis (UC), but no prospective studies have examined endoscopic and ...
Prior research has estimated the rates of avoidant/restrictive food intake disorder (ARFID) to be between 10% and 54% in patients with inflammatory bowel disease (IBD). However, recently published ...
Background/Aims With the recent increase in available treatment options for inflammatory bowel disease (IBD), shared decision-making (SDM) has gained considerable importance. To address potential ...
Background Antitumor necrosis factor (TNF) dose escalation is performed to improve therapeutic response and optimize outcomes in patients with Crohn’s disease (CD). We aimed to describe the ...
Objectives Oral extraintestinal manifestations (OEIMs) of inflammatory bowel disease (IBD) may impact IBD treatment. The aims of this study were to: (1) determine which OEIMs are most prevalent among ...
Background In this nationwide study, we aimed to explore healthcare services utilization, medical management, and disease outcomes of inflammatory bowel diseases (IBD) across the 2 major ethnic ...
Background Clostridioides difficile infection (CDI) is a well-recognized complication of inflammatory bowel disease (IBD) that has been associated with poor clinical outcomes. The objective of this ...
Background Inflammatory IBD has a significant adverse influence on the physical, psychological, family, and social dimensions of patients. This research aims to compare the effectiveness of ACT and ...
Why publish with Crohn's & Colitis 360?
There are many benefits to publishing your paper Open Access with Crohn's & Colitis 360, including global readership, broad discoverability, and high quality review.
Explore journal benefits and resources
Crohn's & Colitis 360 Fellow Initiatives
Crohn's & Colitis 360 offers editorial and publishing opportunities to benefit Early Career Researchers. The journal's initiatives include a year-long Editorial Fellowship and the Fellow's Corner.
Learn more
Email alerts
Register to receive table of contents email alerts as soon as new issues of Crohn's & Colitis 360 are published online.
Sign up
Read and Publish deals
Authors interested in publishing in Crohn's & Colitis 360 may be able to publish their paper Open Access using funds available through their institution’s agreement with OUP.
Find out if your institution is participating
Submit your work
Review the author guidelines and learn how to submit your research to Crohn's & Colitis 360.
An Official Publication
Crohn's & Colitis 360 is an official online-only, open access journal of the Crohn's & Colitis Foundation.
About the Foundation
Professional Education Opportunities
The Foundation is here to support healthcare providers in their efforts to care for patients with IBD through our professional education and training programs. Learn more about our many resources for professionals as well as educational activities.
Learn moreConnect with the Foundation
Stay up to date with the latest news and content from the Foundation:
Become a Foundation Professional Member
By becoming a Professional Member of the Crohn's & Colitis Foundation, you will establish yourself as a leader and specialist in Crohn's disease and ulcerative colitis. In addition, you will gain the support and resources that can help you equip your patients with everything they need to take charge of their digestive diseases.
Learn moreResources to Share
As the nation’s leading source for educational information for Crohn’s disease and ulcerative colitis patients and professionals, the Crohn’s & Colitis Foundation maintains an extensive collection of resources for people diagnosed with these diseases, and other information on IBD.
Learn more
